Indacaterol/glycopyrronium in symptomatic patients with COPD (GOLD B and GOLD D) versus salmeterol/fluticasone: ILLUMINATE/LANTERN pooled analysis

BACKGROUND: Indacaterol/glycopyrronium (IND/GLY) is approved for maintenance treatment of adult patients with COPD. This post hoc analysis explored the efficacy and safety of IND/GLY versus salmeterol/fluticasone (SFC) in symptomatic (Global Initiative for Chronic Obstructive Lung Disease [GOLD] B a...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Int J Chron Obstruct Pulmon Dis
Главные авторы: Vogelmeier, Claus, Zhong, Nanshan, Humphries, Michael J, Mezzi, Karen, Fogel, Robert, Bader, Giovanni, Patalano, Francesco, Banerji, Donald
Формат: Artigo
Язык:Inglês
Опубликовано: Dove Medical Press 2016
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5167461/
https://ncbi.nlm.nih.gov/pubmed/28008244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S116786
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы